Best Life Sciences Companies To Watch For 2014

With the Federal Reserve standing pat this week, the S&P 500 index has reached another all-time high.

Yet this bull market is proving to be even more fertile for investors in small-cap and micro-cap stocks. Both the iShares Russell Microcap Index and the Russell 2000 Small Cap Index are outperforming the S&P 500 by a solid margin over the past two years.

With no end in sight to the bull market, there's no reason to stop focusing on these small companies at this juncture. If the economy can manage to build a head of steam in 2014 and 2015, then these small stocks should see even deeper investor interest.

Here are three stocks that all trade below $5 and sport market values below $500 million -- and are poised for solid upside if this rally continues.

1. Lionbridge Technologies (Nasdaq: LIOX) I took note of heavy insider buying at this language translation services firm back in July, and though shares are up nearly 10% since then, the company's outlook has brightened markedly. 

On the second-quarter conference call, management delivered its most upbeat discussion of business trends in several years, noting that Lionbridge is seeing an expansion in its relationship with Microsoft (Nasdaq: MSFT), the return of several other large tech clients that had dropped off in the past few years, and a rising order book with manufacturing and life sciences clients. 

Hot Gold Stocks To Own For 2015: Brookline Bancorp Inc.(BRKL)

Brookline Bancorp, Inc. operates as the holding company for Brookline Bank, Bank Rhode Island, and The First National Bank of Ipswich, which provide commercial and retail banking services, and cash management and investment services to customers in Central New England. The company accepts various deposit products, including non-interest-bearing checking accounts, interest-bearing NOW accounts, savings accounts and money market savings accounts, certificate of deposit accounts, individual retirement accounts, and other qualified plan accounts. Its loan portfolio comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; auto loans; loans to business entities consisting of commercial lines of credit; and loans to condominium associations, as well as loans for financing equipment used by small businesses. Brookline Bancorp, Inc. also provides financing for construction and development projects, home equity, and other consumer l oans; and loans to finance coin-operated laundry, dry cleaning, and convenience store equipment and businesses. As of January 25, 2012, it operated 43 branches in Massachusetts and Rhode Island. The company was founded in 1871 and is headquartered in Brookline, Massachusetts.

Advisors' Opinion:

• [By Dividends4Life]

  Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers��Index. The company's peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.

• [By CRWE]

  Brookline Bancorp, Inc. (NASDAQ:BRKL) announced today that it will report third quarter earnings 2012 at the close of business Wednesday, October 24, 2012. Management will host a conference call to review this information at 1:30 PM Eastern Time on Thursday, October 25, 2012.

Best Life Sciences Companies To Watch For 2014: SIGA Technologies Inc.(SIGA)

SIGA Technologies, Inc., a pharmaceutical company, engages in the development and commercialization of pharmaceutical solutions for smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Its lead product is ST-246, an orally administered antiviral drug that targets orthopoxviruses. The company also has two drug series in the pre-clinical development stage against four serotypes of virus for dengue disease. In addition, it is developing anti-arenavirus drug for hemorrhagic fever arenaviruses and other hemorrhagic fever viruses, including Rift Valley Fever, Lymphocytic choriomeningitis virus, and Ebola; and a broad spectrum antiviral candidate against viruses in the Poxviridae, Filoviridae, Bunyaviridae, Arenaviridae, Flaviviridae, Togaviridae, Retroviridae, and Picornaviridae families. The company was founded in 1995 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 name pharmaceutical player that's starting to move within range of triggering a big breakout trade is Siga Technologies (SIGA), which discovers, develops, manufactures and commercializes drugs to prevent and treat diseases including smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. This stock is off to a strong start in 2013, with shares up by 35%.

  If you take a look at the chart for SIGA Technologies, you'll notice that this stock has been trending inside of a consolidation pattern for the last two months, with shares moving between $3.16 on the downside and $3.74 on the upside. Shares of SIGA have just started to spike higher above its 50-day moving average at $3.27 a share and it's now moving within range of triggering a big breakout trade above the upper-end of its recent range.

  Market players should now look for long-biased trades in SIGA if it manages to break out above some near-term overhead resistance levels at $3.70 to $3.74 a share and then once it takes out more resistance at $4 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 263,209 shares. If that breakout triggers soon, then SIGA will set up to re-test or possibly take out its 52-week high at $4.60 a share. If that level gets taken out with volume, then SIGA could easily tag its next major overhead resistance levels at $5 to $5.90 a share.

  Traders can look to buy SIGA off weakness to anticipate that breakout and simply use a stop that sits right below its 200-day moving average of $3.26 a share, or below more key support at $3.16 a share. One can also buy SIGA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Monica Gerson]

  SIGA Technologies (NASDAQ: SIGA) is expected to post its Q4 earnings at $0.62 per share on revenue of $47.00 million.

  Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Best Life Sciences Companies To Watch For 2014: Adecoagro S.A. (AGRO)

Adecoagro S.A., an agricultural company, engages in the agricultural, manufacturing, and land transformation activities in South America. It operates through Crops; Rice; Dairy; Coffee; Cattle; Sugar, Ethanol, and Energy; and Land Transformation segments. The company engages in planting, harvesting, and selling grains, oilseeds, wheat, corn, soybeans, cotton, and sunflowers; and providing grain warehousing/conditioning, and handling and drying services to third parties. It is also involved in planting, harvesting, processing, and marketing rice; producing and selling raw milk; cultivating coffee beans and marketing the company�s and third party�s coffee production. In addition, the company engages in the lease of cattle grazing land to a meat processor; cultivation and processing of sugar and ethanol, as well as cogeneration of electricity from sugarcane bagasse; and identification, acquisition, and disposition of farmlands. As of December 31, 2012, it owned a total of 2 83,942 hectares that consisted of 22 farms in Argentina, 15 farms in Brazil, and 1 farm in Uruguay; and had a cogeneration capacity of 148 MW. The company was founded in 2002 and is based in Luxembourg.

Advisors' Opinion:

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated

• [By MONEYMORNING.COM]

  And with very quick gains of 9% in BRF SA (NYSE ADR: BRFS), 5.2% in South American agricultural play Adecoagro SA (NYSE: AGRO) and 1.6% in high-tech agribusiness player Neogen Corp. (Nasdaq: NEOG), we're doing well with our plays on (pockets of) accelerating U.S. inflation.

Best Life Sciences Companies To Watch For 2014: Officemax Incorporated(OMX)

OfficeMax Incorporated, together with its subsidiaries, distributes business-to-business and retail office products. Its Contract segment markets and sells office supplies and paper, technology products and solutions, office furniture, and print and document services directly to large corporate and government offices, as well as to small and medium-sized offices through field salespeople, outbound telesales, catalogs, Internet, and office products stores. As of December 31, 2011, this segment operated 38 distribution centers in the United States, Puerto Rico, Canada, Australia, and New Zealand; 4 customer service and outbound telesales centers in the United States; and 47 office products stores in Canada, Hawaii, Australia, and New Zealand. The company?s Retail segment markets and sells office supplies and paper, print and document services, technology products and solutions, and office furniture to small and medium-sized businesses and consumers through a network of reta il stores. As of December 31, 2011, this segment operated 978 stores in the United States and Mexico; 3 large distribution centers in the United States; and 1 small distribution center in Mexico. The company, formerly known as Boise Cascade Corporation, was founded in 1913 and is headquartered in Naperville, Illinois.

Advisors' Opinion:

• [By Rich Duprey]

  As the merger between office products suppliers OfficeMax (NYSE: OMX  ) and Office Depot (NYSE: ODP  ) wends its way through the regulatory process, they've hired�global talent management consultancy Korn/Ferry International (NYSE: KFY  ) to begin the process of finding a CEO to lead the combined companies once the deal is completed.